Cited 0 time in
Oleandrin and the its derivative odorsoside A, both cardiac enoglycosides, exhibit anti-cancer effects by inhibiting invasion via suppressing the STAT-3 signaling pathway
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | 김혜정 | - |
| dc.contributor.author | 고영신 | - |
| dc.contributor.author | 진하나 | - |
| dc.contributor.author | 박상원 | - |
| dc.contributor.author | 루기라 트로이얀 | - |
| dc.date.accessioned | 2022-12-26T16:32:24Z | - |
| dc.date.available | 2022-12-26T16:32:24Z | - |
| dc.date.issued | 2018-11 | - |
| dc.identifier.issn | 1661-6596 | - |
| dc.identifier.issn | 1422-0067 | - |
| dc.identifier.uri | https://scholarworks.gnu.ac.kr/handle/sw.gnu/11079 | - |
| dc.format.extent | -3332 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | MOLECULAR DIVERSITY PRESERVATION INTERNATIONAL-MDPI | - |
| dc.title | Oleandrin and the its derivative odorsoside A, both cardiac enoglycosides, exhibit anti-cancer effects by inhibiting invasion via suppressing the STAT-3 signaling pathway | - |
| dc.type | Article | - |
| dc.publisher.location | 스위스 | - |
| dc.identifier.bibliographicCitation | International Journal of Molecular Sciences, v.19, no.11, pp 3350 - 17 | - |
| dc.citation.title | International Journal of Molecular Sciences | - |
| dc.citation.volume | 19 | - |
| dc.citation.number | 11 | - |
| dc.citation.startPage | 3350 | - |
| dc.citation.endPage | 17 | - |
| dc.description.isOpenAccess | Y | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0532
COPYRIGHT 2022 GYEONGSANG NATIONAL UNIVERSITY LIBRARY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
